Form 4 for ELTX Elicio Therapeutics, Inc.
Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-05 · accession 0000950170-25-035494 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-03-07 | 2025-03-05 | ELTX | Chudnovsky Yekaterina | Dir, 10% | C - Cnv Deriv | $5.81 | +3.50M | 5.42M | +183% | +$20.34M |
| DI | 2025-03-07 | 2025-03-05 | ELTX | Chudnovsky Yekaterina | Dir, 10% | C - Cnv Deriv | $5.81 | -3.44M | 0 | -100% | -$20.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-05 | C | A | 3,500,573 | $5.81 | 5,416,212 | I Held by GKCC, LLC | — | — | (F1) Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC. |
| 2 | Derivative | Convertible Note (convertible into Common Stock) | 2025-03-05 | C | D | 3,442,341 | $5.81 | 0 | I Held by GKCC, LLC | $5.81 · — to — | 3,442,341 Common Stock | (F1) Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC. (F2) The Convertible Note had a stated maturity date of February 15, 2026. The Convertible Note, including any accrued but unpaid interest, was converted into shares of Common Stock on March 5, 2025 at a conversion price of $5.81 per share. |